Clinical Trials

Radiation Oncology Associates participates in a wide range of clinical trials, allowing access to the most advanced treatment options for cancer patients in the greater Fort Wayne community. ROA partners with the following research groups in order to deliver the most state of the art treatments possible: Hoosier Oncology Group, Southwest Oncology Group, Children’s Oncology Group, CALGB Cancer and Leukemia Group, and the National Surgical Adjuvant Breast and Bowel Project.
 

Most recently, Radiation Oncology Associates was qualified to enroll patients in Intensity-Modulated Radiation Therapy (IMRT) clinical trials by the Radiation Therapy Oncology Group (RTOG). This qualification is not only prestigious, but is only granted to a select group of radiation oncology providers who perform an outstanding job in treating patients with IMRT. “We practice high quality state-of-the-art radiation therapy for all types of malignancies. We participate in investigational Phase II and randomized Phase III clinical trials designed by national cooperative study groups, pediatric oncology studies and CALGB and RTOG. We are active in Hoosier Oncology Group’s (HOG) organizational activities, and, as a founding member, I serve on the board of directors and as a member of Clinical Trials Working Group,” said Dr. Prasad Mantravadi.